FDA Approved: VFEND — Supplemental Application (Roerig)

View source ↗

Summary

FDA approved a supplemental application for Vfend (voriconazole) submitted by Roerig.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Esophageal Candidiasis
• Fusariosis
• Invasive Aspergillosis
• Invasive Candidiasis
• Scedosporiosis

Drugs mentioned

• VFEND (Voriconazole)

Snippet

SUPPL AP for VFEND (VORICONAZOLE)